Immunadd Immunadd
  • Technology
    • Our Pipeline
    • Our Adjuvants
    • Our Patent
  • News & Events
  • About
    • ImmunAdd at a Glance
    • Our Founder and CEO
    • Our Philosophy
  • Contact
default-logo
  • Home
  • Technology
    • Our Pipeline
    • Our Adjuvants
    • Our Patent
  • News & Events
  • About
    • ImmunAdd at a Glance
    • Our Founder and CEO
    • Our Philosophy
  • Contact
  • 繁中
News
_ 2024-01-18

IP Australia Has Granted ImmunAdd a Patent for “SAPONIN CONJUGATE AND VACCINE OR PHARMACEUTICAL COMPOSITION COMPRISING THE SAME”

TAIPEI, Taiwan Jan 18, 2024 – IP Australia has granted ImmunAdd the patent on the synthetic saponin molecules. Innovation for Better Health We are ImmunAdd.

LEARN MORE
News
_ 2024-01-13

Canadian Intellectual Property Office Has Granted ImmunAdd a Patent for “SAPONIN CONJUGATE AND VACCINE OR PHARMACEUTICAL COMPOSITION COMPRISING THE SAME”

TAIPEI, Taiwan Jan 13, 2024 – Canadian Intellectual Property Office has granted ImmunAdd the patent on the synthetic saponin molecules. “Innovation for Better Health” We are ImmunAdd.

LEARN MORE

Home

Technology

Our Pipeline

Our Adjuvants

Our Patent

About

Immunadd at a Glance

Our Founder and CEO

Our Philosophy

News&Event

Contact

Office:

11 F.-8, No. 130, Sec. 2, Zhongxiao E. Rd., Zhongzheng Dist., Taipei City 100411, Taiwan (R.O.C.)

© 2024 immunadd. All rights reserved.